Comparative prognostic performance of risk scores for 12-month mortality and rehospitalization after transcatheter tricuspid valve intervention. [PDF]
Schlegl J +9 more
europepmc +1 more source
Time to assess more than prognosis
We provide an overview about the current landscape of transcatheter tricuspid valve interventions (TTVI) and summarize recent findings from trials including TRILUMINATE, TRILUMINATE Pivotal, bRIGHT, TRICLASP, TRISCEND, TRISCEND II, TRICUS, and Cardioband
Rudolph, Volker (PD Dr. med.) +5 more
core
Surgical and Transcatheter Tricuspid Valve Interventions: An Electrophysiology-Focused Review. [PDF]
Tang KS +6 more
europepmc +1 more source
Tricuspid Regurgitation: Pathophysiology, Risk Stratification, and Implications for Intervention. [PDF]
Piscione M +10 more
europepmc +1 more source
Focus on tricuspid valve-the European perspective. [PDF]
Möllmann H +11 more
europepmc +1 more source
The Two-Device Problem: A Comprehensive Framework for Managing Transvalvular CIED Leads in the Era of Transcatheter Tricuspid Intervention. [PDF]
Kamareddine MH +4 more
europepmc +1 more source
Transcatheter and surgical management of tricuspid valve disease: multidisciplinary lifetime management considerations. [PDF]
de Waha S +6 more
europepmc +1 more source
Echocardiographic guidance in transcatheter tricuspid valve interventions. [PDF]
Kam KKH, Vannan M, Lee APW.
europepmc +1 more source
Association of Predicted Surgical Risk With 3-Year Outcomes After Isolated Tricuspid Valve Surgery: An Analysis of Medicare Beneficiaries. [PDF]
Mehaffey JH +6 more
europepmc +1 more source
State of the art: Transcatheter tricuspid valve intervention. [PDF]
Wilcox J +17 more
europepmc +1 more source

